Tokyo Tape
Sign in
← Kaken Pharmaceutical

Quarterly report · Q3

4521.TEDINET S100Q58K
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥55.6bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥76.0bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥57.7bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥12.4bn2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥13.9bn2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥13.0bn2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥17.5bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥14.3bn2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥12.6bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥14.5bn2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥9.1bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥9.5bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥10.2bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥9.1bn2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥10.2bn2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥167.8bnat 2022-12-31Cons.Assets
Total assets¥165.2bnat 2022-03-31Cons.Assets
Total assets¥169.9bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥27.1bnat 2022-12-31Cons.Liabilities
Total liabilities¥26.9bnat 2022-03-31Cons.Liabilities
Net assets / equity¥140.7bnat 2022-12-31Cons.Net assets
Net assets / equity¥138.3bnat 2022-03-31Cons.Net assets
Net assets / equity¥139.7bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥55.9bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥61.0bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥243.312022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥84.992022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥251.432021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥269.412021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥93.22021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio83.5%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio83.4%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio81.9%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q3r_E00935-000Medicinereportable segmentrevenue2022-04-01 → 2022-12-31¥53.8bn
jpcrp040300-q3r_E00935-000Medicinereportable segmentrevenue external2022-04-01 → 2022-12-31¥53.8bn
jpcrp040300-q3r_E00935-000Medicinereportable segmentsegment profit2022-04-01 → 2022-12-31¥11.4bn
jpcrp040300-q3r_E00935-000Real Estatereportable segmentrevenue2022-04-01 → 2022-12-31¥1.8bn
jpcrp040300-q3r_E00935-000Real Estatereportable segmentrevenue external2022-04-01 → 2022-12-31¥1.8bn
jpcrp040300-q3r_E00935-000Real Estatereportable segmentsegment profit2022-04-01 → 2022-12-31¥960m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥55.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥55.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥12.4bn
jpcrp040300-q3r_E00935-000Medicinereportable segmentrevenue2021-04-01 → 2021-12-31¥55.9bn
jpcrp040300-q3r_E00935-000Medicinereportable segmentrevenue external2021-04-01 → 2021-12-31¥55.9bn
jpcrp040300-q3r_E00935-000Medicinereportable segmentsegment profit2021-04-01 → 2021-12-31¥12.9bn
jpcrp040300-q3r_E00935-000Real Estatereportable segmentrevenue2021-04-01 → 2021-12-31¥1.8bn
jpcrp040300-q3r_E00935-000Real Estatereportable segmentrevenue external2021-04-01 → 2021-12-31¥1.8bn
jpcrp040300-q3r_E00935-000Real Estatereportable segmentsegment profit2021-04-01 → 2021-12-31¥998m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-12-31¥57.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-12-31¥57.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-12-31¥13.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 381
ItemContextValueUnit
Profit lossPrior1YTDDuration10246000000JPY
Profit lossCurrentYTDDuration9149000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration－JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration－JPY
Profit loss attributable to owners of parentPrior1YTDDuration10246000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration9149000000JPY
Profit lossPrior1YTDDuration10246000000JPY
Profit lossCurrentYTDDuration9149000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration624000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration146000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration59000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration47000000JPY
Other comprehensive incomePrior1YTDDuration684000000JPY
Other comprehensive incomeCurrentYTDDuration193000000JPY
Comprehensive incomePrior1YTDDuration10930000000JPY
Comprehensive incomeCurrentYTDDuration9343000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration10930000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration9343000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration－JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration－JPY
Net sales of finished goods and merchandisePrior1YTDDuration_jpcrp040300-q3r_E00935-000MedicineReportableSegmentsMember54882000000JPY
Net sales of finished goods and merchandisePrior1YTDDuration_jpcrp040300-q3r_E00935-000RealEstateReportableSegmentsMember－JPY
Net sales of finished goods and merchandisePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember54882000000JPY
Net sales of finished goods and merchandisePrior1YTDDuration_ReconcilingItemsMember－JPY
Net sales of finished goods and merchandisePrior1YTDDuration54882000000JPY
RoyaltyPrior1YTDDuration_jpcrp040300-q3r_E00935-000MedicineReportableSegmentsMember1024000000JPY
RoyaltyPrior1YTDDuration_jpcrp040300-q3r_E00935-000RealEstateReportableSegmentsMember－JPY
RoyaltyPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember1024000000JPY
RoyaltyPrior1YTDDuration_ReconcilingItemsMember－JPY
RoyaltyPrior1YTDDuration1024000000JPY
Other incomePrior1YTDDuration_jpcrp040300-q3r_E00935-000MedicineReportableSegmentsMember－JPY
Other incomePrior1YTDDuration_jpcrp040300-q3r_E00935-000RealEstateReportableSegmentsMember1802000000JPY
Other incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember1802000000JPY
Other incomePrior1YTDDuration_ReconcilingItemsMember－JPY
Other incomePrior1YTDDuration1802000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E00935-000MedicineReportableSegmentsMember55906000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E00935-000RealEstateReportableSegmentsMember1802000000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember57708000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration57708000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E00935-000MedicineReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E00935-000RealEstateReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember－JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember－JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q3r_E00935-000MedicineReportableSegmentsMember55906000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q3r_E00935-000RealEstateReportableSegmentsMember1802000000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember57708000000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember－JPY
Net salesPrior1YTDDuration57708000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass